BioStem Technologies annual total assets
2021
2022
2023
2024
2025
BioStem Technologies Total Assets Growth & History (BSEM)
BioStem Technologies's total assets was $50.0M for fiscal 2025.
View full BioStem Technologies company overviewBioStem Technologies annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $50.0M | −$8.3M | −14.22% |
| 2024 | 2024-12-31 | $58.3M | $43.8M | +300.53% |
| 2023 | 2023-12-31 | $14.6M | $11.1M | +320.04% |
| 2022 | 2022-12-31 | $3.5M | $794,918 | +29.76% |
| 2021 | 2021-12-31 | $2.7M | — | — |
BioStem Technologies quarterly total assets
Q4.24
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $48.8M | — | — |
| Q4 2025 | 2025-12-31 | $50.0M | −$90.3M | −64.36% |
| Q3 2025 | 2025-09-30 | $62.4M | — | — |
| Q4 2024 | 2024-12-31 | $140.4M | — | — |
BioStem Technologies total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's total assets increased from $2.7M to $50.0M, a change of $47.4M. The latest reported quarter, Q2 2026, shows $48.8M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioStem Technologies source filings ↗